Effect of selenium in combination with adriamycin or taxol on several different cancer cells

Anticancer Research

Volumn 20, Issue 3 A, 2000, Pages 1391-1414

  Vadgama, Jaydutt V ^a   Wu, Yanyuan ^a   Shen, Dejun ^a   Hsia, S ^a   Block, Jerome ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Adriamycin; Anticancer; Apoptosis; Breast; Intestine colon; Liver; Lung; Ovarian; Prostate; Selenium; Taxol

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; PACLITAXEL; SELENIUM;

AMINO ACID TRANSPORT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL CYCLE G2 PHASE; CELL GROWTH; CELL STRAIN CACO 2; COLON CANCER; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; HUMAN; HUMAN CELL; LIVER CANCER; LUNG CANCER; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER;

AMINO ACIDS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BIOLOGICAL TRANSPORT; BREAST NEOPLASMS; CELL DIVISION; CELL MEMBRANE; CELL SIZE; COLONIC NEOPLASMS; DNA FRAGMENTATION; DOXORUBICIN; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; INTESTINAL NEOPLASMS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; OVARIAN NEOPLASMS; PACLITAXEL; PROSTATIC NEOPLASMS; SELENIUM; TUMOR CELLS, CULTURED;

EID: 0033863728     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Lu J, Pei H, Ip C, Lisk DJ, Ganther H and Thompson HJ: Effect of an aqueous extract of selenium-enriched garlic on in vitro markers and in vivo efficacy in cancer prevention. Carcinogenesis 17: 1903-1907, 1996.
2. Ip C, El-Bayoumy K, Upadhaya P, Ganther H, Vadhanavikit S and Thompson H: Comparative effect of inorganic and organic seleno-cyanate derivatives in many cancer chemoprevention. Carcinogenesis 15: 187-192, 1994.
3. Clark LC, Combs GF, Turnbull BW, Slate EH, Chalker DO, Chow J, Davis LS, Glover RA, Graham IGF, Gross NG, Konrad A, Lecher JL, Park K, Sanders BB, Smith CL and Taylor R: Effects of selenium supplementationforcancerpreventioninpatientswithcarcinomaofthe skin. J. Am. Med. Assoc 276: 1957-1985, 1996.
4. Blot WE, Li J-Y, Taylor PR, Go W, Dawsey S, Wang G-Q, Yang C-S, Zheng Y-H, Gail M, Li-G-Y, Yu Y, Liu B-Q, Tangrea J, Sun Y-h, Liu F, Fraumeni JF, Zhang Y-H and Li B: Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in general population. J Natl Cancer Inst 85: 1483-1492, 1993.
5. Yu, S.-Y, Zhu JJ, Li WG, Huang Q-S, Zhi-Huang C, Nan-Zang Q and Hou C: A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in china. Biol. Trac Element Res 29: 289-294, 1991.
6. Ujiie S, Itoh T and Kikuchi H: Seum selenium contents and the risk of cancer. Gan To Kagaku Ryoho, 25(12): 1891-1897, 1998.
7. Gail MH, You WC, Chang YS et al: Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: design issues and initial data. Control Clinical trials, Aug; 19(4): 352-69, 1998.
8. Kaeck M, Lu J, Strange R, Ip C, Ganther HE and Thompson HJ: Differential induction of growth arrest inducible genes by selenium compounds. Biochemical Pharmacology 53: 921-926, 1997.
9. Fornace AJJr, Alamo IJr and Hollander MC: DNA damage-inducible transcripts in mammalian cells. Proc Natl Acad Sci USA 85: 8800-8804,
10. Soule HD, Maloney TM, Wolman SR, Peterson WD Jr, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF and Brooks SC: A human cell line from a patient with pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51: 1409-1416, 1973.
11. Fogh J, Fogh JM and Orfeo T: One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 59: 221-226, 1977.
12. Soule HD et al: Isolation and characterization of a spontaneously immortalized human breast epithelial MCF- 10. Cancer Res 50: 6075-6086, 1990.
13. Zhang JQ, Wang SX and Chen CW: Biologic and morphologic characteristics of the Bcap-37 human breast cancer cell line. Chung Hua Wai Ko Tsa Chih 23(4): 241-243, 1985.
14. Bullions LC, Notterman DA, Chung LS and Levine AJ: Expression of wild-type alpha-catenin protein in cells with a mutant alpha-catenin gene restores both growth regulation and tumor suppressor activities. Mol Cell Biol 17(8): 4501-4508, 1997.
15. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA and Murphy GP: LNCaP model of human prostatic carcinoma. Cancer Res 43: 1809-1818, 1983.
16. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF and Jones LW: Establishment and characterization of human prostatic carcinoma cell line (PC-3). Invest Urol 17: 16-23, 1979.
17. Huang M, Wang J, Lee P, Sharma S, Mao JT, Meissner H, Uyemura K, Modlin R, Wollman J and Dubinett SM: Humna non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Research 55: 3847-3853, 1995.
18. Dharmsathaphorn K, McRoberts JA, Mandel KG, Tisdale LD and Masui H: A human colonic tumor cell line that maintains vectorial electrolyte transport. Am J Physiol 246: G204-G208, 1984.
19. Hidalgo IJ, Raub TJ and Borchardt RT: Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96(3): 736-749, 1989.
20. Zhang ZG, Malmberg M, Yin MB, Slocum HK and Rustum YM: Isolation and characterization of a human ileocecal carcinoma cell line (HCT-8) subclone resistant to flurodeoxyuridine. Biochem Pharmacol 45(5): 1157-1164, 1993.
21. Knowles BB, Howe CC and Aden DP: Human hepalocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 209: 497-499, 1980.
22. Pieters R, Loonen AH, Huismans DR, Broekema GJ, Dirven MWJ, Heyenbrok MW, Hahlen K and Veerman AJP: In vitro sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions. Blood 76: 2327, 1990.
23. Kaspers GJL, Veerman AJP, Pieters R, Zantwijk IV, Hahlen K and Van Wering ER: Drug combination testing in acute lymphoblastic leukemia using the MTT assay. Leukemia Research 19: 175-181, 1995.
24. Sun X, Snowden R, Dinsdale D, Ormerod M and Cohen G: Changes in nuclear chromatin precede internucleosomal DNA cleavage in the induction of apoptosis by etoposide. Biochem Pharmacol 47: 187-195, 1994.
25. Bhalla K, Ibrado A, Tourkin E, Tang C, Mahoney M and Huang Y: Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia, 7: 563-568, 1993.
26. Vadgama JV: Design of Simple Devices to Measure Solute Fluxes: and Binding in Monolayer Cell 26 Cultures. Methods in Enzymology Biomembranes 171: 133-144, 1989.
27. Gazzola GC, Dall'Asta V and Guidotti GG: J Biol Chem 255: 929-936, 1980.
28. Vadgama JV and Christensen HN: Comparison of System N in Fetal Hepatocytes and in Related Cell Lines. J Biol Chem 258: 6422-6429, 1983.
29. Christensen HN, Makowske M and Vadgama JV: Changes in Amino Acid Transport Systems on Maturation and Transformation of Rat Hepatocytes. In Isolation, Characterization, and Use of Hepatocytes (Harris RA, and Cornell NW, eds) Elsevier Scientific PubCo, NY p. 217-226, 1983.
30. Vadgama JV, Chan M and Wu J: Differential Expression of Amino Acid Transport Systems A and ASC during Erythroleukemia Cell Differentiation. Am J Physiol 260 (Cell Physiology 29), C392-C399, 1991.
31. Hsia S: Personal communication.
32. Thompson HJ, Wolson A, Lu J, Singh M, Liang C, Upadhyaya P, El-Bayoumy K and Ip C: Comparison of the effects of an organic and inorganic form of selenium on a mammary carcinoma cell line. Carcinogenesis 15: 183-186, 1994.
33. Reddy BS, Upadhyaya P, Simi B and Rao CV: Evaluation of organo-selenium compounds for potential chemopreventive properties in colon carcinogenesis. Anticancer Res 14: 2509-2514, 1994.
34. Saunders DE, Lawrence WD, Christensen C, Wappler N, Ruan H and Deppe G: Paclitaxel-induced apoptosis in MCF-7 breast cancer cells. Int J Cancer 70: 214-220, 1997.
35. Donaldson KL, Goosby GL and Wahl AF: Cytotoxicity of the anticancer agents cisplatin and Taxol during cell proliferation and the cell cycle. Int J Cancer 57: 847-855, 1994.
36. Ip C: Lessons from basic research in selenium and cancer prevention. J Nutrition 128: 1845-1854, 1998.
37. Harrison PR, Lanfear J, Wu L, Fleming J, McGarry I and Blower L: Chemopreventive and growth inhibitory effects of selenium. Biomedical and Environmental Sciences 10: 235-245, 1997.
38. Gallegos A, Berggren M, Gasdaska JR and Powis G: Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium. Cancer Res 57: 4964-4970, 1997.
39. Berggren M, Gallegos A, Gasdaska PY, Warneke J and Powis G: Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and effects of serum stimulation and hypoxia. Anticancer Res 16: 3459-3466, 1996.
40. Gasdaska PY, Oblong JE, Cotgrave IA and Powis G: The predicted amino acid sequence of human thioredoxin is identical to that of the autocrine growth factor human adult T-cell derived factor (ADF): thioredoxin mRNA is elevated in human tumors. Biochim Biophys. Acta 1218: 292-296, 1964.
41. Stewart MS, Davis RL, Walsh JP and Pence BC: Induction of differentiation and apoptosis by sodium selenite in human colonic carcinoma cells HT29. Cancer Lett 117: 35-40, 1997.
42. Redman C, Xu MJ, Peng YM, Scott JA, Payne C, Clark LC and Nelson MA: Involvement of polyamines in selenomethionine induced apoptosis and mitotic alterations in human tumor cells. Carcinogenesis 18(6): 1195-202, 1997.
43. McGarrity T, Peiffer L and Hartle R: Effect of selenium on growth, S-adenosylmethionine and polyamine biosynthesis in human colon cancer cells. Anticancer Res 13: 811-816, 1993.
44. Yang M and Sytkowski AJ: Differential expression and androgen regulation of the human selenium- binding protein gene hSP56 in prostate cancer cells. Cancer Res 58(14): 3150-3153, 1998.
45. Combs IGF and Gray WP: Chemopreventive agents: selenium. Pharmacol Ther 79(3): 179-192, 1998.